Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Global Cord Blood Corporation (CO)

    Price:

    2.99 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    CO
    Name
    Global Cord Blood Corporation
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    Price
    2.988
    Market Cap
    400.084M
    Enterprise value
    -3.693B
    Currency
    USD
    Ceo
    Ting Zheng
    Full Time Employees
    1202
    Ipo Date
    2007-01-25
    City
    Central
    Address
    Bank of China Tower

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Danaher Corporation

    VALUE SCORE:

    0

    Symbol
    DHR-PA
    Market Cap
    151.660B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    2nd position

    Danaher Corporation

    VALUE SCORE:

    7

    Symbol
    DHR
    Market Cap
    151.660B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    The best

    Quest Diagnostics Incorporated

    VALUE SCORE:

    9

    Symbol
    DGX
    Market Cap
    20.154B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    2.694
    P/S
    1.196
    P/B
    0.277
    Debt/Equity
    0.000
    EV/FCF
    -8.713
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    -4.161
    Earnings yield
    0.371
    Debt/assets
    0.000
    FUNDAMENTALS
    Net debt/ebidta
    -10.142
    Interest coverage
    0
    Research And Developement To Revenue
    0.018
    Intangile to total assets
    0.010
    Capex to operating cash flow
    0.032
    Capex to revenue
    0.016
    Capex to depreciation
    0.413
    Return on tangible assets
    0.059
    Debt to market cap
    0.000
    Piotroski Score
    8.000
    FUNDAMENTALS
    PEG
    0.007
    P/CF
    4.240
    P/FCF
    4.827
    RoA %
    5.871
    RoIC %
    6.264
    Gross Profit Margin %
    85.256
    Quick Ratio
    10.655
    Current Ratio
    10.726
    Net Profit Margin %
    40.303
    Net-Net
    26.298
    FUNDAMENTALS PER SHARE
    FCF per share
    4.885
    Revenue per share
    10.228
    Net income per share
    4.122
    Operating cash flow per share
    5.048
    Free cash flow per share
    4.885
    Cash per share
    54.800
    Book value per share
    40.189
    Tangible book value per share
    39.501
    Shareholders equity per share
    40.142
    Interest debt per share
    0.001
    TECHNICAL
    52 weeks high
    3.590
    52 weeks low
    0.600
    Current trading session High
    3.320
    Current trading session Low
    2.220
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.619
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -114.905
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -63.656
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -18.415
    logo

    Country
    CN
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.011

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Equipment & Services
    Dividend yield
    0.010353009%
    Payout Ratio
    31.713386999999997%
    P/E
    30.427
    logo

    Country
    GB
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.010

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    33.091
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -89.189
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -4.682
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0.0029739777%
    Payout Ratio
    11.881962399999999%
    P/E
    38.802
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    -103.81039999999999%
    P/E
    -3.172
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -20.135
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.028
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    27.192
    DESCRIPTION

    Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

    NEWS
    https://images.financialmodelingprep.com/news/co-corbf-deadline-rosen-top-ranked-investor-counsel-encourages-20240624.jpg
    CO, CORBF DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF

    globenewswire.com

    2024-06-24 13:18:00

    NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/co-corbf-deadline-co-corbf-investors-have-the-opportunity-20240622.jpg
    CO, CORBF Deadline: CO, CORBF Investors Have the Opportunity to Lead Global Cord Blood Corporation Securities Fraud Lawsuit

    prnewswire.com

    2024-06-22 08:15:00

    NEW YORK , June 22, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of all purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by June 24, 2024.

    https://images.financialmodelingprep.com/news/investor-deadline-approaching-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-global-20240621.jpg
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord

    globenewswire.com

    2024-06-21 12:15:00

    NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Global Cord Blood Corporation (“Global Cord” or the “Company”) (NYSE: CO, OTC: CORBF) and reminds investors of the June 24, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

    https://images.financialmodelingprep.com/news/rosen-a-trusted-and-leading-law-firm-encourages-global-20240620.jpg
    ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF

    globenewswire.com

    2024-06-20 19:54:00

    NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/rosen-a-highly-recognized-law-firm-encourages-global-cord-20240616.jpg
    ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF

    globenewswire.com

    2024-06-16 16:47:00

    NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-20240614.jpg
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)

    globenewswire.com

    2024-06-14 10:00:00

    LOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 24, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) securities between June 4, 2019 and May 3, 2022, inclusive (the “Class Period”).

    https://images.financialmodelingprep.com/news/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-20240613.jpg
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines – CORBF

    globenewswire.com

    2024-06-13 10:38:00

    NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) and certain officers.   The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24-cv-03071, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Global Cord securities between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

    https://images.financialmodelingprep.com/news/rosen-a-leading-law-firm-encourages-global-cord-blood-20240612.jpg
    ROSEN, A LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF

    globenewswire.com

    2024-06-12 18:04:00

    NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/investor-deadline-approaching-faruqi-faruqi-llp-investigates-claims-on-behalf-of-20240612.jpg
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord

    globenewswire.com

    2024-06-12 11:25:00

    NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Global Cord Blood Corporation (“Global Cord” or the “Company”) (NYSE: CO, OTC: CORBF) and reminds investors of the June 24, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

    https://images.financialmodelingprep.com/news/rosen-law-firm-urges-global-cord-blood-corporation-nyse-20240611.jpg
    Rosen Law Firm Urges Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) Stockholders With Large Losses to Contact the Firm for Information About Their Rights

    businesswire.com

    2024-06-11 17:26:00

    NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline. SO WHAT: If you purchased Global Cord securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr.

    https://images.financialmodelingprep.com/news/global-cord-blood-corporation-investors-looming-deadline-in-class-20240611.jpg
    Global Cord Blood Corporation Investors: Looming Deadline in Class action lawsuit filed on behalf of investors; the Portnoy Law Firm

    globenewswire.com

    2024-06-11 11:56:00

    Investors can contact the law firm at no cost to learn more about recovering their losses.

    https://images.financialmodelingprep.com/news/rosen-trusted-investor-counsel-encourages-global-cord-blood-corporation-20240610.jpg
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF

    prnewswire.com

    2024-06-10 16:00:00

    NEW YORK , June 10, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the "Class Period"), of the important June 24, 2024 lead plaintiff deadline. SO WHAT: If you purchased Global Cord securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

    https://images.financialmodelingprep.com/news/rosen-trusted-investor-counsel-encourages-global-cord-blood-corporation-20240607.jpg
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CO, CORBF

    globenewswire.com

    2024-06-07 17:05:00

    NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline.

    https://images.financialmodelingprep.com/news/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-20240607.jpg
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)

    globenewswire.com

    2024-06-07 15:38:00

    LOS ANGELES, June 07, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 24, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) securities between June 4, 2019 and May 3, 2022, inclusive (the “Class Period”).

    https://images.financialmodelingprep.com/news/shareholder-action-reminder-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-global-20240606.jpg
    SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord

    prnewswire.com

    2024-06-06 11:20:00

    NEW YORK , June 6, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Global Cord Blood Corporation ("Global Cord" or the "Company") (NYSE: CO, OTC: CORBF) and reminds investors of the June 24, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Global Cord To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 investing in Global Cord stock or options between June 4, 2019 and May 3, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext.

    https://images.financialmodelingprep.com/news/corbf-stockholders-contact-robbins-llp-for-information-about-the-20240605.jpg
    CORBF STOCKHOLDERS: Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Global Cord Blood Corporation Class Action

    globenewswire.com

    2024-06-05 14:39:00

    SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Global Cord Blood Corporation (OTC: CORBF) securities between June 4, 2019 and May 3, 2022. Global Cord Blood provides umbilical cord blood storage and ancillary services in the in the Beijing Municipality, Guangdong Province, and Zhejiang Province of the People's Republic of China.